长病程1型糖尿病患者的病程与慢性并发症与免疫激活相关
该横断面研究纳入243例长病程1型糖尿病患者,于2016年2月至2017年6月在荷兰Radboudumc招募,检测免疫细胞表型与功能及循环炎症蛋白组。HbA1c水平与循环炎症标志物正相关(P < .05),糖尿病病程与循环免疫细胞数量及炎症蛋白组增加相关(P < .05),糖尿病肾病与循环免疫细胞及炎症标志物增加相关(P < .05)。
要点
- HbA1c水平与循环炎症标志物正相关(P < .05),但与免疫细胞数量及表型无关。
- 糖尿病病程与循环免疫细胞数量及炎症蛋白组增加相关(P < .05)。
- 糖尿病肾病与循环免疫细胞及炎症标志物增加相关(P < .05)。
核心结论
- 病程和慢性并发症与长病程1型糖尿病患者免疫反应的持续改变相关。
研究设计与样本
- 横断面研究,纳入243例长病程1型糖尿病患者,于2016年2月至2017年6月在荷兰Radboudumc招募。
- 采血检测免疫细胞表型与功能及循环炎症蛋白组,采用多变量线性回归分析HbA1c水平、糖尿病病程、胰岛素需求量及糖尿病并发症与炎症的关联。
主要发现
- HbA1c水平与循环炎症标志物正相关(P < .05),但与免疫细胞数量及表型无关。
- 糖尿病病程与循环免疫细胞数量增加(P < .05)、炎症蛋白组增加(P < .05)相关,且与针对结核分枝杆菌(Mycobacterium tuberculosis)和米根霉(Rhizopus oryzae)的适应性免疫反应负相关(P < .05)。
- 糖尿病肾病与循环免疫细胞增加(P < .05)及炎症标志物增加(P < .05)相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Type 1 diabetes (T1D) is associated with alterations of the immune response which persist even after the autoimmunity aspect is resolved. Clinical factors that cause dysregulation, however, are not fully understood. OBJECTIVE: To identify clinical factors that affect immune dysregulation in people with longstanding T1D. DESIGN: In this cross-sectional study, 243 participants with longstanding T1D were recruited between February 2016 and June 2017 at the Radboudumc, the Netherlands. Blood was drawn to determine immune cell phenotype and functionality, as well as circulating inflammatory proteome. Multivariate linear regression was used to determine the association between glycated hemoglobin (HbA1c) levels, duration of diabetes, insulin need, and diabetes complications with inflammation. RESULTS: HbA1c level is positively associated with circulating inflammatory markers (P < .05), but not with immune cell number and phenotype. Diabetes duration is associated with increased number of circulating immune cells (P < .05), inflammatory proteome (P < .05), and negatively associated with adaptive immune response against Mycobacterium tuberculosis and Rhizopus oryzae (P < .05). Diabetes nephropathy is associated with increased circulating immune cells (P < .05) and inflammatory markers (P < .05). CONCLUSION: Disease duration and chronic complications associate with persistent alterations in the immune response of individuals with long standing T1D.
引用
- Ajie M, van Heck JIP, Janssen AWM, et al. Disease Duration and Chronic Complications Associate With Immune Activation in Individuals With Longstanding Type 1 Diabetes. J Clin Endocrinol Metab. 2023. PMID: 36800223. doi:10.1210/clinem/dgad087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。